Sanofi SA
NASDAQ:SNY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sanofi SA
NASDAQ:SNY
|
FR |
|
L
|
L E Lundbergforetagen AB (publ)
SWB:LU3B
|
SE |
|
W
|
Westinghouse Air Brake Technologies Corp
XETRA:WB2
|
US |
|
Aramark
NYSE:ARMK
|
US |
|
Broadcom Inc
MIL:1AVGO
|
US |
|
Tokio Marine Holdings Inc
TSE:8766
|
JP |
Wall St Price Targets
SNY Price Targets Summary
Sanofi SA
According to Wall Street analysts, the average 1-year price target for SNY is 56.15 USD with a low forecast of 33.25 USD and a high forecast of 67.92 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SNY's stock price target?
Price Target
56.15
USD
According to Wall Street analysts, the average 1-year price target for SNY is 56.15 USD with a low forecast of 33.25 USD and a high forecast of 67.92 USD.
What is the Revenue forecast for Sanofi SA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Sanofi SA?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.
What is the Operating Income forecast for Sanofi SA?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 14%.
What is the Pre-Tax Income forecast for Sanofi SA?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Sanofi SA?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 16%.
